Get started
Author

Fernando Sánchez Loria

Observed names: F Sanchez Loria, F. Sanchez Loria, F. Sánchez Loria, FERNANDO SÁNCHEZ LORIA, Fernando Sanchez Loria, Fernando Sánchez-Loria
ORCID: 0000-0001-9708-0649
Observed ORCID: 0000-0001-9708-0649
OpenAlex ID: A5022816454
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
2018 · Maxime J M van der Valk, Denise E Hilling, et al. · The Lancet · 1,128
PDF
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study
2020 · Laura M Fernandez, Guilherme P São Julião, et al. · The Lancet Oncology · 215
PDF
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
2012 · Yamila S Rocca, María P Roberti, et al. · Innate Immunity · 138
Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15
2016 · Yamila Sol Rocca, María Paula Roberti, et al. · Frontiers in Immunology · 98
PDF
Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study
2014 · JUAN MANUEL O’CONNOR, FABIANA MARMISSOLLE, et al. · Molecular and Clinical Oncology · 65
PDF
Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival
2011 · Juan Martín Arriaga, Estrella Mariel Levy, et al. · Human Pathology · 60
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy
2023 · Carine El Sissy, Amos Kirilovsky, et al. · Journal of Clinical Oncology · 54
PDF
Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer
2024 · Laura M. Fernandez, Guilherme P. São Julião, et al. · Journal of Clinical Oncology · 38
Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years
2021 · Renu R Bahadoer, Koen C M J Peeters, et al. · British journal of surgery · 38
PDF
Non-surgical management of rectal cancer. Series of 68 cases, long follow up in two leading centres in Argentina
2016 · Fernando Sanchez Loria, Soledad Iseas, et al. · Digestive and Liver Disease · 36
CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide.
2005 · Reinaldo Chacón, Gabriela Tossen, et al. · PubMed · 22
Dramatic Responses to Therapy in Rare Tumors
2005 · Reinaldo Chacón, Gabriela Tossen, et al. · Journal of Clinical Oncology · 19
Dramatic Responses to Therapy in Rare Tumors
2005 · Matías Chacón, Enrique Roca, et al. · Journal of Clinical Oncology · 16
PDF
Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer
2012 · J.M. Arriaga, I.A. Bravo, et al. · Human Pathology · 14
Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina
2022 · Federico Esteso, Natalia Soledad Tissera, et al. · World Journal of Clinical Oncology · 13
Prognostic Impact of K-Ras Mutational Status and Primary Tumor Location in Patients Undergoing Resection for Colorectal Cancer Liver Metastases: An Update
2019 · Juan M O´ Connor, Fernando Sanchez Loria, et al. · Future Oncology · 9
Outcomes of watch and wait after short-course radiotherapy in an international multicentre watch-and-wait cohort
2024 · Barbara M Geubels, Aart-Jan van den Esschert, et al. · British journal of surgery · 7
PDF
International validation of the Immunoscore-biopsy (ISB) to guide selection and monitoring of patients treated with watch-and-wait (WW) strategy for rectal cancer.
2022 · Franck Pages, Carine El Sissy, et al. · Journal of Clinical Oncology · 3
Prognostic impact of K-RAS mutational status and primary tumour location in patients undergoing resection for colorectal cancer liver metastases: A METHEPAR analysis (multicentre study in Argentina)
2018 · J. O’Connor, E. Huertas, et al. · Annals of Oncology · 3
Complete Remission With Imatinib in Metastatic Gastrointestinal Stromal Tumors
2005 · Matías Chacón, Enrique Roca, et al. · Journal of Clinical Oncology · 3
Short-course radiotherapy for rectal cancer: real-world evidence in Argentina
2023 · Natalia S Tissera, Berenice Freile, et al. · ecancermedicalscience · 2
PDF
Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model
2023 · Natalia S. Tissera, Federico Esteso, et al. · Journal of Gastrointestinal Oncology · 2
PDF
Towards precision medicine in colorectal cancer liver metastases
2020 · Juan Manuel O’Connor, Fernando Sanchez Loria · Hepatic Oncology · 1
Meta-analysis of KRAS mutation as prognostic factor in patients (pts) with resection of colorectal (CRC) liver metastases: Tumour burden and Sidedness analysis
2019 · M.R. Luca, M. Angel, et al. · Annals of Oncology · 1
Mri-based Peritoneal Protocol as a Predictor of Surgical Tumor Burden in Interval Debulking Surgery for Advanced Ovarian Cancer in Low-middle Income Countries.
2026 · Maria Cecilia Coria, Mauro Orlando, et al. · International Journal of Gynecological Cancer
Works count: 34
Citation count: 1,985
H-index: 14
I10-index: 15
Year
Topic
Type